For veterinary surgeons and VNs who missed out on the BVDA 'Improving Periodontal Health' lecture tour last year, a further six have been organised for this autumn.
Speakers include Norman Johnston BVM&S, MRCVS, Ex President of the European Veterinary Dental College, John Robinson BDS (Lond) Dentist to the Veterinary Profession and Lisa Milella BVSc, MRCVS President of the British Veterinary Dental Association (BVDA). This year's events see the content extended to include resorptive lesions, fractured teeth and dental radiography with greater emphasis on feline oral care.
According to Lisa, the 2010 lecture series helped alert vets and VNs to the importance of oral health, benefitting both pet and practice. "It takes five years at vet school to qualify yet only three or four days are devoted to dentistry, so it's no surprise that many vets and VNs enter the profession with only a basic understanding of oral health.
"We know that four out of five dogs over the age of three show signs of periodontal disease but unfortunately many go untreated. This is mainly because the problems that this can lead to are not fully understood."
She added: "These seminars will not only help delegates to recognise early signs of oral disease but also offer practical guidance on how practices can educate pet owners in the importance of oral care."
Lisa believes that both practices and owners benefit from good oral hygiene programmes. "As a profession we need to do more to help educate pet owners in the value of good oral care. Practices should be talking to their clients from day one about preventative programmes, rather than wait until the damage is done."
The six UK events are:
The evening seminars, which are open to both vets and nurses, contribute two hours CPD and cost £35 per person and £25 for each subsequent delegate. A special group rate of £100.00 is available for any practice that wishes to send a group of four. For anyone wanting to reserve a place, please call the BVDA lecture tour reservation line centre on 01664 415 503.
Dechra Veterinary Products has produced a pair of presentations, aimed at pet owners, for vets to use in receptions and at client events. The presentations cover canine hyperadrenocorticism, aka Cushing's syndrome, and feline hyperthyroidism.
Matthew Olsen, Product Manager, said: "We are committed to delivering a wide range of support materials and tools to enable vets to provide help and information to their customers. We have developed an owners' booklet on both Cushing's and hyperthyroidism and have now backed this up with PowerPoint presentations for vets to use with their clients. Some veterinary practices are using technology to revolutionise waiting room displays and we have responded to their needs by producing a presentation they can use on their waiting room information screens."
The Dechra Hyperadrenocorticism presentation covers what Cushing's is, what causes it and what owners need to look for. The presentation also explains the treatment options available. The Hyperthyroidism presentation details what the condition is and gives information on the thyroid gland. It highlights what cat owners need to look out for, including weight loss in spite of a ravenous appetite, increased fluid intake and increased restlessness. The presentation also advises people of what to do should they suspect their cat has hyperthyroidism and what the treatment options are.
Garden Lodge Veterinary Clinic in Holywood, County Down, has used the Hyperthyroidism presentation at both its practices. Partner Tom Fitzsimons said: "We have used the presentation on our reception information screens. The presentation has raised owners' awareness and shown them it is a manageable condition. It's led to an increase in the number of cats we are now testing for Hyperthyrodism. We also plan to run the Cushing's presentation in the future."
Veterinary Practices interested in getting hold of a free copy of the Hyperthyrodism and Hyperadrenocorticism presentations should contact Matthew Olsen at Dechra on 01743 441 632 or email matthew.olsen@dechra.com
Bayer Animal Health has launched four short youtube films about parasites, fronted by celebrity veterinary surgeon, Scott Miller.
The press blurb says the films "will provide pet owners with an amazing and educational journey into the world of parasites and highlight the need for the control of these often unwelcome pests", which I would normally translate as: "will provide anyone with too much time on their hands with a rather dull five minute advertisement for our flea treatment".
But no. The big surprise is that in addition to the slick production values, these films actually are rather interesting. I've just watched the first, and learned a bit about the vampire bat. There's some compelling infra-red footage of some of them feeding on a sleeping horse.
Elsewhere in the You Tube clips, Scott discusses other parasites including fleas, ticks and worms, and shows the harm they can inflict if owners don't sufficiently protect their cats and dogs with appropriate treatments. On that score, he urges owners to seek veterinary advice. Scott also discusses the threats posed by the increasing urbanisation of foxes and by exotic diseases that are now being found much further north as a result of climate change.
Matt Frost, UK marketing manager at Bayer Animal Health, says: "The clips, all of which are around four minutes in length, provide an opportunity for pet owners to learn more about parasites in a novel and entertaining way. We hope that viewers will learn more about the inherent dangers some of these creatures pose to pets and the steps that can be taken to protect against them.
The other clips can be viewed online at www.youtube.com/user/parasitesundercover1. You might even like to embed them from youtube into your own practice website.
Pfizer Animal Health has launched a dedicated Equine Business Unit to provide a higher level of service and a comprehensive range of products to equine vets across the UK.
Created following the merger with Fort Dodge, the Pfizer Equine Business Unit is headed by Ben Lacey MA Vet MB MRCVS, who has previously held both technical and sales roles at Pfizer. Ben and his team have a brief to offer a breadth of product, support and flexibility not previously available to equine vets.
The product range offered by the Pfizer Equine Business Unit includes the Equest range of parasiticides; the Duvaxyn vaccines for Equine Herpes Virus, West Nile Virus and Rotavirus and products such as Equimidine and Torbugesic. Also offered are existing Pfizer brands such as the Equip vaccine range, the antibiotic Excenel Sterile Powder, the NSAID Rimadyl for Horses and Depo-MedroneV.
Five experienced account managers with a strong track record in the equine sector have been appointed by Pfizer to build relationships with equine vet practices on a regional basis. They are:
South East England Mark BakerWest Midlands, Cheshire, Wales Laurie MayEast Anglia, East Midlands Penny McCannSouth West, South Wales Anna CunninghamThe North, Scotland Alexandra Cox
Ben Lacey said: "Building our new team and combining the highly regarded products offered previously by both Fort Dodge and Pfizer has proved a stimulating process. We've also worked closely with many of our existing practice customers to look at how we can develop the service we provide to them.
"We're now able to offer a product range which I believe is unrivalled in the market and a highly committed team of equine professionals, who share a vision and passion for equine health. We're looking forward to building our business with both existing and new customers in the months ahead."
CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints which, says CEVA, is considered to be one of the most common forms of hindlimb lameness in the horse.
The double-blind, multicentric, placebo-controlled trials were carried out on a total of 108 pleasure horses, show jumpers and eventers of a variety of sizes and breeds, all of which had been clinically diagnosed with bone spavin. The horses were rigorously selected, having to show clinical signs of spontaneous lameness of at least six weeks but less than a year's duration and had to be in daily exercise. Horses suffering proximal suspensory desmitis were excluded.
Horses were defined as suffering from bone spavin if they displayed a chronic hindlimb lameness which improved with distal tarsal joint analgesia and showed radiographic evidence of bony changes associated with bone spavin in the distal tarsal joints. The horses were treated at day zero with a single Tiludronate infusion or a placebo and reassessed 60 days later after a period of controlled exercise.
Eighty seven horses completed the trials, comprising 42 Tiludronate treated horses and 45 placebo cases. By day 60 approximately 60% of the Tiludronate treated horses had improved in lameness by two grades or more, scored on a ten point system.
Horses with bone spavin experience abnormal bone remodeling changes, occasionally with excessive bone resorption in the tarsal bones. Tiludronate works by regulating this bone remodeling through a decrease in the resorptive process, slowing down the degradation of the bone structure when the condition is progressing and alleviating the pain associated with abnormal bone lysis.
CEVA has recently produced a leaflet specifically to help horse owners to understand the diagnosis and treatment of bone spavin. For copies of this leaflet and CEVA's comprehensive veterinary brochure on the product please contact CEVA Animal Health on 01494 781510 or visit the website at http://www.tildren.com/
Tiludronate infusion in the treatment of bone spavin: A double blind placebo-controlled trial
Reference M. R. GOUGH*, D. THIBAUD† and R. K. W. SMITH‡ (*CEVA Animal Health, Bucks, UK; †CEVA Animal Health USA, Kansas, USA; and ‡Department of Veterinary Clinical Sciences, The Royal Veterinary College, University of London, UK). Equine vet. J. (2010) 42 (5) 381-387 doi: 10.1111/j.2042-3306.2010.00120.x
New research released today by Petplan has revealed that at a time when marriage is in decline and the average child bearing age is increasing, a new breed of pet owner has emerged: women between the ages of 25 and 34 who bought their pet as a substitute for a child.
More than 10,000 pet owners were surveyed for the research and the results apparently reveal 'pet parenting' as a growing trend. According to the survey, women not only look to their furry friend for companionship but also treat them like they would a child, with nearly 70% buying them birthday and Christmas presents, 28% adapting their homes for their pet and 20% changing their holiday destinations to allow their pet to come along too.
Just like working parents, owners worry about leaving their pet alone when they're working. So much so that they make a concerted effort to make sure their pet is not left alone for more than five hours a day - employing dog walkers and cat sitters to stem their concern (approaching 1 in 7). When an 8 hour working day is the national norm and the average parent only spends 49 minutes a day with their children, this demonstrates considerable pet commitment.
Dr Deborah Wells, expert in the study of the psychology of the pet-human relationship said: "Dogs and cats can offer their owners many of the benefits frequently provided by children, including companionship, entertainment and happiness. For some owners, notably women, pets can provide a useful training ground in 'motherhood', in some cases helping to shape important decisions on whether or not children are to be a part of their future. For others, pets can serve as a child 'substitute', offering people who choose not to have, or cannot conceive, children, an outlet for emotional attachment and nurturing behaviour."
Petplan's marketing manager Alison Andrew said: "This pet parenting theme is one of the most significant trends to come out of Petplan's biggest body of research to date - the Petplan Pet Census - which looks into the realities of pet ownership. We see the amazing lengths that owners go to for their pets every day and the level of worry that goes with it. Our job is to give owners peace of mind through our insurance plans, so they can be confident their beloved companion will always receive the best care and treatment without having to worry about the financial costs. We want to use this research to truly understand modern pet ownership in the UK so that we can better provide help and guidance for our nation of pet lovers!"
If you'd like to take part in the Petplan Pet Census, documenting the picture of pet ownership in Britain, visit www.petplan.co.uk
Medivet, the practice group which is to feature in the forthcoming Panorama documentary It shouldn't happen at a vets' (9pm, July 22nd), has issued a statement concerning the programme.
The statement, which can be read in full here, includes an interview with a Medivet client who was in turn interviewed for the documentary:
The International Society of Feline Medicine (ISFM) has published 'Consensus Guidelines on the Long-term use of NSAIDs in cats' in the July 2010 edition of the Journal of Feline Medicine and Surgery.
The society says it has developed the guidelines in order to try and address the major welfare issue of cats suffering unremitting and untreated chronic pain. Until recently, NSAIDs had only been licensed for short-term use in cats, but with changing licensing indications and recommendations, they are now also increasingly used for long-term treatment of cats, for example in the management of osteoarthritis.
However, in most cases where long-term use of pain relief in cats is required, there are concomitant problems with other diseases or other drugs that are being given. According to the ISFM, one of the most common concerns is whether NSAIDs can be used to treat arthritis in older cats with kidney disease. The society says that because of concerns like these, and the potential for adverse effects, cats often receive no treatment at all, and their quality of life can be severely compromised.
For this reason, the ISFM set up an international expert panel to develop practical and rational guidelines on the long-term use of NSAIDs in cats. The aim was to provide guidelines that would empower clinicians, enabling them to make sensible and rational choices, and ensure much-needed therapy is not needlessly withheld from patients.
The panel was made up of Andrew Sparkes, Duncan Lascelles, Richard Malik, Sheilah Robertson, Margie Scherk, Polly Taylor, Llibertat Real Sampietro and Reidun Heiene.
Along with the veterinary information in the guidelines, the panel also developed a brief client-facing leaflet that can be given to owners when NSAIDs are prescribed for their cats - this leaflet provides simple, clear advice on why NSAIDs are used, why they are important, but also what simple precautions avoid adverse effects, with further advice on when to seek veterinary advice to reinforce the safety message.
Both of these publications are available to download from the website www.isfm.net/toolbox
Genitrix has announced the launch of Prilben (benazapril hydrochloride). The product joins its 'Standards' range, created to offer veterinary practices cost-effective versions of frequently used products.
Prilben is indicated for the treatment of congestive heart failure in dogs and for chronic renal insufficiency in cats. It is provided in packs of 14 x 5mg tablets at a veterinary list price of £4.50, which equates to 32p per tablet.
Rob Watkins, Marketing Director at Genitrix, said: "Benazapril hydrochloride is a tried and trusted medicine used in countless practices and homes across the country every day. Prilben offers a win for both practices and pet owners because its pricing structure enables practices to maintain profitability on the product whilst still providing their clients with an economical alternative."
The first product in Genitrix' Standards range, Dormilan, was launched in late 2009 and offers fast-acting sedation and analgesia for dogs and cats.
CEVA Animal Health has published an information booklet on Q Fever to help broaden awareness and understanding of the disease.
Q Fever is an emerging, worldwide disease that affects goats, cattle and sheep as well as humans. It is caused by the bacterium Coxiella burnetii and can induce late abortions, metritis, fertility problems, mastitis and low vitality in neonates born from carrier animals.
The new booklet explains how the disease is transmitted, the symptoms, diagnosis and how it can be managed and prevented. CEVA already have expertise in the treatment of diseases caused by Coxiella burnetii and have developed a vaccine that has been used under temporary license to control outbreaks in France and the Netherlands.
To obtain a copy of the booklet please contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG. The proceedings from CEVA's recent symposium on Q fever, held in Marseilles in December 2009 are also available on request.
Veterinary practices are being encouraged to enter the annual Veterinary Marketing Association's (VMA) awards, which now include a practice-only category.
The annual VMA awards are intended to recognise excellence in all aspects of veterinary and animal health marketing. The Practice Marketing Award, sponsored by Pfizer, is awarded to the companion or production animal practice that demonstrates the most initiative and innovation in the marketing of its products and/or services to end users. This can involve the use of any form of activity, including advertising, websites, direct mail and media relations.
Last year's winner of this award was Kessock Equine Vets from Aberdeen, who travelled down to London to receive their award at a presentation lunch. The 2009 awards presentation ceremony takes place on Friday, 19th March at the Old Brewery in Chiswell Street, London. The meeting also presents a very good opportunity for vets to meet representatives from all the major animal health companies.
Tickets for the event cost £115+VAT for VMA/VMPA members (£150+VAT for non-members). The price includes a three-course meal (prepared by a two-star Michelin chef) with wine, a champagne reception and entertainment by a top comedian.
Further information on the awards is available on the Veterinary Marketing Association's website - http://www.vma.org.uk/. Closing date for entries is 5th February 2010.
Eskimo, a reindeer at Edinburgh Zoo has received life-saving surgery just in time for Christmas, making him the first reindeer in history to receive keyhole surgery.
Vet Romain Pizzi successfully removed one of Eskimo's testes, which had been lodged in its abdomen since birth, using specialist surgical instruments donated to the zoo by one of Ark Surgical's strategic partners Surgical Innovations.
The zoo was worried that the retained testicle may have been developing into a tumour giving off abnormal hormones, and that this could become life-threatening. Thankfully, zoo surgeons found that the retained testicle, although abnormally sized, had not yet developed a tumour.
It is thought that the abnormal testicle was affecting Eskimo's production and flow of testosterone and, as a result, he was showing submissive behaviour and being bullied by the other male reindeer in the herd. He had also started to show some abnormal and delayed antler growth and development. Removing the testicle will halt any abnormal hormone production so hopefully Eskimo will return to full vigour just in time for Christmas.
Gavin O'Brien, Director at Ark Surgical said: "We were only too happy to help when Romain mentioned the challenging operation faced by Eskimo and in the season of goodwill we approached Surgical Innovations who kindly donated the instruments for this pioneering surgery."
Although laparoscopic surgery is routine in humans, the standard procedure in animals is still open abdominal surgery. Open abdominal surgery is 20 years behind human medical advances and has a number of negative factors on animals such as more post-operative pain, slower recovery and a higher risk of post-operative complications and infections.
Romain, a veterinary surgeon for the Royal Zoological Society of Scotland, based at Edinburgh Zoo, said: "Laparoscopic surgery is still very uncommon in veterinary medicine, even amongst common species such as dogs, cats and horses, so for keyhole surgery to be carried out on a reindeer shows a great advancement in veterinary surgery."
It is estimated that nearly one out of every two households in the UK are pet owners. Veterinary surgeons perform on average 600,000 open abdominal procedures annually but it is believed that less than 1% of vets currently practice laparoscopic surgery.
Romain believes that with the right instrumentation available through innovative companies such as Ark Surgical, UK vets now have more opportunity than ever to introduce laparoscopic techniques as part of their operating procedures.
Romain said: "This procedure was only really possible thanks to a cutting-edge designed retractor which we were able to use in this case. Ironically although a reindeer is a reasonably large animal, due to their unique anatomy and massive four chambered stomach that takes up most of the space in the abdomen, there is a very limited internal operating space. For this reason the operation was much more difficult than in a human, or in a dog, where there is more space to work, despite their smaller size."
"We were especially pleased with how quickly Eskimo recovered after surgery, he was standing and happily eating lichen again within 10 minutes of recovery from anaesthesia. He hardly seemed to notice he had even had surgery, although he was still slightly groggy from the anaesthesia. This would simply not have been possible with traditional open abdominal surgery, as the long wound would have been much more painful and debilitating."
The minimally invasive nature of laparoscopic surgery means there are numerous benefits for animals such as a reduction in post-operative pain, a faster recovery and reduced post-operative care. It also has a decreased risk of infection after surgery and a lower risk of any wound complications.
For veterinary surgeons laparoscopic surgery can offer better visualisation of the operated area, allowing them to be more precise and reach areas that are difficult to see in open surgery such as the liver and pelvic canal.
Romain carries out laparoscopic operations on dogs, cats and exotic pets at his own veterinary practice Inglis Veterinary Centre (Scotland) and has pioneered several new laparoscopic techniques.
He said: "Laparoscopic surgery has so many benefits for the animal, the veterinary surgeons and the zoo, so there is no reason why it should not be more common practice within veterinary surgery. I hope Eskimo's experience helps raise its profile and encourage more veterinary surgeons to look in to it as a standard surgical procedure."
Ark Surgical offers a wide range of laparoscopy instruments and peripherals to vets across the UK and to suit all budgets. The company says it is already working with many of the UK's leading vets and agencies such as the Royal Zoological Society of Scotland, as well as the UK foremost laparoscopic medical device manufacturer Surgical Innovations, to be at the forefront of veterinary laparoscopic surgery
For more information on animal laparoscopic surgery contact Ark Surgical on 01732 862882 or http://www.arksurgical.co.uk/
Research amongst veterinary surgeons by Janssen Animal Health, maker of Cavalesse oral and Cavalesse topical, has revealed that owners could be doing more harm than good when it comes to managing sweet itch in their horses.
92% of vets questioned are aware that people follow old wives' tales by administering lotions and potions such as garlic and olive oil to ward off flies during the summer sweet itch season, when garlic actually has the opposite effect of attracting them.
According to Janssen, it is thought that only a quarter of horse owners are aware that it is important to carry out preventative measures before the start of the midge season to help alleviate sweet itch. 14% of people are thought to go to their vet for advice on sweet itch, while 30% seek help from their country store or tack shop, 27% search for information on websites and 26% ask other horse owners for guidance. This is despite the fact that 92% of those questioned believe that sweet itch would clear up quicker if people sought advice from their veterinary surgeon.
Nicki Glen, marketing manager at Janssen Animal Health said: "Sweet itch can be an incredibly difficult and frustrating condition to manage, however horse owners do not tend to seek advice from their vets. It is therefore important to educate horse owners while you are on yard visits with pro-active advice on the condition for the long-term health and welfare of horses."
Cavalesse is a natural food supplement containing a specialised formulation of water-soluble vitamins and minerals, including nicotinamide. Once a month the contents of each sachet are dissolved in water to form an oral solution, which can be administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat such as a sugar lump. Janssen says the supplement helps horses maintain a healthy skin and promotes normal immune function in horses prone to summer allergies.
Cavalesse Topical is a skincare gel that can be used in combination with the Cavalesse solution. The gel can be applied to the skin to help support natural immunity from the outside, whilst the oral solution works in partnership from the inside.
For further information on Cavalesse and Cavalesse Topical please contact your Janssen Animal Health account manager or phone 01494 567555.
Veterinary Nurses are being invited to comment on National Occupational Standards (NOS) as Lantra, the Sector Skills Council for environmental and land-based industries, announced today that further consultation meeting dates have been set for January and February.
Individuals and organisations representing veterinary nursing are being invited to get involved in shaping the NOS for their industry and ensure they accurately reflect today's way of working and the role of veterinary nurses in practice.
Lisa Jarvis, Lantra's Partnership Manager for veterinary nursing and a RVN herself, said: "NOS identify the detailed knowledge, understanding, ability and experiences somebody needs to carry out their job effectively. Lantra works hard with industry to make sure they fit their needs and is continuing the consultation process by holding a number of additional meetings in January and February."
The additional meetings will take place at Antrim, Northern Ireland (12 January, 11.00 to 14.30), Lantra House, Warwickshire (14 January and 17 February, 10.30 to 15.30) and a meeting at the College of Animal Welfare in Edinburgh, Scotland (23 February).
Lisa Jarvis continued: "These newly added meeting dates will give all those interested parties, who missed the first set of meetings, the opportunity to come along and define the standards for today's veterinary nurse. We want as many people to get involved as possible but if you can't join us at a meeting, you can register with us to take part in the online consultation that will follow later in January and February."
Lantra ensures that all industries represented in their footprint have up-to-date and accurate National Occupational Standards. The standards help businesses improve performance and productivity as they can be used to identify the skills needed for their workforce, highlight best practice, develop training and recruitment plans and develop job descriptions.
If you would like to take part in any of the meetings or the online consultation to help industry get the most out of the skills system, please visit www.lantra.co.uk/nos, call Lantra on 02476 858 424 or register your interest by emailing standardsandquals@lantra.co.uk.
A research project funded by equine charity The Horse Trust has succeeded in killing equine sarcoid cells in vitro by silencing a gene in the virus that causes sarcoids. The researchers are now hoping to obtain funding for clinical trials using the new technique, which could result in a more effective, non-toxic treatment for sarcoids.
Sarcoids are skin tumors caused by infection with the Bovine Papillomavirus (BPV). They are the most common type of tumour found in horses - the estimated prevalence in the UK is 6-7%. Although the disease is rarely life threatening, many horses with sarcoids are euthanased because the condition is untreatable or because the horse is unsellable. Currently there is no universally effective treatment for sarcoids and if treatment fails the sarcoids will often come back worse.
However, research that was given funding by The Horse Trust offers a potential ray of hope for owners of horses affected by sarcoids. The research was published in Virus Research journal earlier this year.
The research, which was led by Professor Lubna Nasir of the University of Glasgow, found that by inhibiting the activity of a particular viral protein within sarcoid cells, the amount of viral DNA in the cells reduced. This led to a reduction in the growth of the sarcoid cells and caused the cell to die by Programmed cell-death (PCD). The researchers believe that PCD occurs because the sarcoid cells become reliant on the virus.
Professor Nasir said: "This could potentially be a major breakthrough in the treatment of sarcoids. We are now seeking funding to use this technique in clinical trials on horses that have sarcoids."
The research team inhibited the activity of a viral protein called E2, which is needed by BPV to replicate. They used a novel approach termed 'gene silencing' to suppress the activity of the gene that codes the E2 protein. The research was carried out in vitro on fibroblast cells, which had been cultured from sarcoid tissue removed from animals during surgery.
As this research was carried out in vitro, the researchers will now need to see if they can replicate the results in vivo, by developing a way of targeting the sarcoid cells in horses.
"One of the challenges with gene silencing is administering it within clinical setting - as you need to get molecules into every cell. As sarcoids are on the surface of a horse, we think administration should be relatively easy - potentially by injecting or applying a cream to the sarcoid," said Professor Nasir. "If we are able to successfully develop this technique it would be a non-toxic and easy to administer treatment for horses affected by this distressing condition."
Nasir's research could also have an impact on the treatment of lesions in cattle, which are also caused by BPV. Around 50% of cattle in the UK are estimated to have lesions. It may also help with the treatment of Human Papillomavirus (HPV) infections in humans. HPV, which is similar to BPV, can lead to various cancers in humans including cervical and vaginal cancer.
Paul Jepson, Chief Executive and Veterinary Director of The Horse Trust said: "We are really excited that the research we have funded could lead to a major breakthrough in the treatment of sarcoids."
The deadline for candidate nominations for the RCVS and VN Council elections is fast approaching - so please hurry if you plan to stand.
There are six seats on the RCVS Council, and two on the VN Council, due to be filled in the 2010 election, but candidate nominations must be received by 31 January 2010.
Jane Hern, RCVS Registrar said: "Getting regulation right is something that all Members and Listed/Registered VNs have power to influence. We know from the reaction we get when we propose changes or ask for your comments that vets and VNs are not backwards about coming forwards - and, like us or loathe us, what the RCVS does impacts directly on the lives of veterinary surgeons and nurses, their clients and patients."
The elections will be held in March, and decided by all veterinary surgeons and veterinary nurses who use their vote. The results will be announced early in May, with those elected taking their seats at RCVS Day in July and serving four-year terms.
All prospective candidates need to provide the signatures and registered/listed addresses of two proposers, and should also submit a short biography, 'manifesto' and photograph for inclusion in the elections booklets. Nobody can nominate more than one candidate, and no current member of the RCVS Council or VN Council may nominate anyone.
Newly elected RCVS Council members should expect to sit on at least one committee which, together with Council attendances, means a time commitment of at least six to eight days a year. Those elected to the VN Council should expect to spend approximately six to eight days attending Council meetings, working parties and subcommittees. Both RCVS Council and VN Council members' expenditures on hotels and travel are reimbursed. Their employers can also claim a standard day-rate for loss of earnings.
Nomination forms and full details relating to RCVS Council nominations can be downloaded from www.rcvs.org.uk or obtained by contacting the Executive Office (020 7222 0761 or executiveoffice@rcvs.org.uk). Nomination forms and details relating to the VN Council can be requested from Annette Amato (020 7202 0788 or a.amato@rcvs.org.uk). All nominations must be made in writing on the prescribed form and received by the Registrar on or before the closing date of 31 January 2010.
All veterinary surgeons, veterinary nurses and VN students are to be invited to take part in an RCVS survey of their profession and, for the first time, these surveys will measure mental wellbeing at a population level.RCVS Registrar, Jane Hern said: "Both surveys are being undertaken on our behalf by the Institute of Employment Studies - an independent research organisation. As in previous surveys, all the data will be anonymised by the IES before being shared with us. This will ensure individuals cannot be identified."The information will provide a snapshot of the veterinary profession and help the RCVS to understand and analyse changing trends. Some of the anonymised data will also be shared with researchers at Defra and at the School of Medicine, University of Southampton, who will analyse selected topics in more depth.Jane added: "These surveys produce very useful information about the veterinary and veterinary nursing profession, not least because they usually get a good response rate.
"We will use the information, for example, in our discussions about new veterinary legislation, 24/7 and the Professional Development Phase for newly-qualified vets. So please make sure that you send the form to the IES - or fill it in online - before 8 February."The RCVS normally surveys veterinary surgeons every four years, and last surveyed veterinary nurses in 2008. To obtain concurrent data regarding vets and VNs, both these surveys are taking place at the same time. Forms can by sent back in the freepost envelope provided, or completed online at www.employmentresearch.co.uk/vs2010.htm (vets) and www.employmentresearch.co.uk/vn2010.htm (VNs). The findings of previous studies can be found at www.rcvs.org.uk/surveys.
Dorwest Herbs has highlighted research that suggests a highly rational mode of action for kelp seaweed as an aid in the treatment of obesity when used alongside a weight reduction diet. The company is asking vets and nurses to look at the evidence and consider using licensed herbal medicines to help cats and dogs lose weight naturally. To help you evaluate the product, Dorwest is giving away 50 trial packs of Kelp Seaweed Tablets.
Mary Boughton MBE, Quality Director at Dorwest Herbs and the UK's leading specialist in the formulation of veterinary herbal medicines said: "We have lots of evidence that Kelp Seaweed Tablets work as an aid in the treatment of obesity but traditional explanations were based on the effect of iodine supplementation on thyroid function as a mode of action. That just didn't hold water for us. However, in common with many conventional medicines, the mechanisms for mode of action of herbal medicines are often not known. So, it was with some excitement that we heard of research that demonstrated that fucoxanthin, a pigment found in kelp, upregulates expression of UCP1 (uncoupling protein) and produces weight loss in the same region as conventional anti-obesity drugs."
Various studies estimate pet obesity may affect 30 to 60 per cent of pets in the UK and arthritis, heart disease and diabetes are just some of the diseases that occur with increasing frequency in obese pets. The research indicates that fucoxanthin has an effect on glucose metabolism and may lower the risk of coronary heart disease in humans. Phlorotannins found in brown seaweed have also recently been indentified as interfering with both the onset and consequences of osteoarthritis. Mary Boughton points out that multiple effects are often seen when herbal treatments are used, "Herbal treatments contain thousands of plant derived chemical compounds and are known for their diverse action, as opposed to the 'magic bullet' effect seen with conventional medicines. In a condition such as obesity where we see many disruptions of normal metabolism and several co-morbid conditions, choosing a herbal treatment makes sense. Kelp Seaweed Tablets are the logical alternative."
Dorwest has prepared a fully referenced technical information sheet detailing recent scientific studies and data from herbal formularies with reference to the role of kelp seaweed in obesity management.
To help vets and nurses further evaluate Kelp Seaweed Tablets - a licensed herbal medicine - used as part of a weight management programme the company is giving away 50 FREE trial packs containing seven weeks of Kelp Seaweed Tablets for a large breed dog, a case report sheet and the technical information sheet. There is also a prize of £100 of John Lewis shopping vouchers for the most informative case report received before the end of February 2010. There is one pack available per practice, while stocks last.
To request a technical information sheet or pack call Dorwest Herbs on 01308 897272.
Genitrix is offering a free poster-sized treatment and dispensing guide for small animals. Designed to be pinned on the consulting room or dispensary wall, the poster sets out key data, including active ingredients, species information and application advice for the company's range of anti-parasite treatments for rabbits, ferrets, rodents, reptiles, birds and other exotic pets.
These include the ivermectin-based Xeno topical spot-on and spray range; Xenex Ultra, the permethrin-based topical spot-on preventive treatment for flystrike; Lapizole, a fenbendazole-based oral treatment for E.cuniculi and Mycozole, a miconazole-based spray for fungal infections, including ringworm.
Rob Watkins, Marketing Director at Genitrix, said: "The treatment guide provides easy to use and clear information on all our small animal products and their use for the practice team."
To request a free poster, please contact Genitrix on 01403 786345 or by email to mail@genitrix.co.uk
A Dogs Trust Glasgow resident who made the news last January for being so obese he could not even walk has lost almost half his body weight.
Patch, a six year old Beagle Cross, weighed the same as an average six year old child - 4.5 stones (28.45kg) - when he was brought to the Rehoming Centre last year.
Staff desperately hoped 2009 would see him find a new home and see him shed almost half his bodyweight to reach his goal of 2.4 stone (15kg). After finding a new home with the MacLean family in Motherwell, exactly one year after hitting the headlines Patch is within sniffing distance of his target by weighing in at 2.9 stone (18kg).
Vets had warned that a rapid weight loss would put strain on Patch's organs and could actually harm him, so it has been a slow, careful process. He follows a strict diet and his exercise levels have been built up gradually, with careful monitoring by veterinary staff.
Claire Kelman, Dogs Trust Glasgow Assistant Centre Manager, said: "When Patch first came to us he was so obese he couldn't even walk and needed a sling to be moved from one place to another. Now he's lost the weight he can run around and properly enjoy his walks like any other dog.
It just goes to show a good diet and careful exercise can make a real impact, so maybe he can be a shining example for everyone feeling a bit bloated after the Christmas break!"
Images courtesy Centre Press Agency
Janssen Animal Health has announced that it has acquired the distribution rights for a range of sedatives and anaesthetics for small and large animals, including Dexdomitor, Domitor and Antisedan.
Janssen aquired the marketing and distribution rights, which were previously held by Pfizer Inc, from Orion Corporation.
Dr. Enno Gottschalk , Janssen's European Director Marketing and Sales said: "This acquisition of distribution rights results in the perfect combination of proven and effective products with the outstanding service and technical selling capabilities of Janssen Animal Health. The products include the sedative Dexdomitor and Domitor, as well as the antagonist Antisedan. Among large animals, predominantly horses, the sedative injection Domosedan is now on offer as part of the Janssen Animal Health portfolio."
The Kennel Club has broadly welcomed Professor Sir Patrick Bateson's 'Independent Inquiry into Dog Breeding', which has recommended that steps be taken to tackle irresponsible breeders and to change the way the public think about buying dogs.
The Kennel Club, which commissioned and funded the report in conjunction with Dogs Trust, welcomes the report's focus on irresponsible breeders who farm puppies with little concern for their welfare and those who sell poorly socialised puppies on to owners to use as 'status dogs' or as fighting weapons.
The Kennel Club agrees that additional training and support needs to be given to local authorities, which are responsible for issuing breeding licences to those people who breed five or more litters of puppies in a single year, as the current provisions are deemed to be ineffective. It agrees that compulsory microchipping of dogs and increased public education to stop people falling prey to puppy farmers and to help them find responsible breeders are necessary.
It is also glad that the report recognises the need for a 'robustly policed and well respected quality assurance scheme', consisting of breeders that buyers can trust to look after their puppies' health and welfare, and that it suggests that the Kennel Club's Accredited Breeder Scheme, with some modification could be used.
However, the Kennel Club is concerned that the report could have gone further and that its recommendations do not appear directly to cover those breeders who breed less than five litters per year and who are not part of the Kennel Club Accredited Breeder Scheme. The Kennel Club would have liked to have seen a recommendation for regulation to ensure that these breeders follow higher standards, such as compulsory health testing.
Caroline Kisko, Kennel Club spokesperson, said: "Whilst the report recognises that the majority of breeders are responsible, there are those whose actions are bringing the rest of the dog breeding community into disrepute and this needs to be stopped.
"We are glad that the report recognises that the Kennel Club has made a good start in its efforts to unite responsible breeders within its Accredited Breeder Scheme, for the benefit of puppies and puppy buyers, and we believe that this should be the basis for moving forward. We are currently working towards UKAS accreditation of the scheme as suggested by Professor Bateson.
"We agree that responsible breeders should be rewarded and believe that the show ring is the best forum for this. The report recognises that 'dog showing and judging are a powerful lever for change' and the Kennel Club is dedicated to ensuring that only the healthiest dogs are rewarded at shows.
"Public education is vital and all dog welfare organisations must continue to work together to ensure that people know what to look for when buying a dog."
The report looks at genetic diversity in breeds and recognises that the Kennel Club has banned close matings. It advises that future decisions about matings that could affect genetic diversity should be 'breed specific' and made upon evidence based scientific information and advice. To this end it is recommended that the veterinary profession should gather data to show the prevalence of certain diseases and that an advisory council should develop evidence based breeding strategies.
Mrs Kisko continued: "The Kennel Club has long recognised that genetic diversity plays a crucial role in safeguarding the health of dogs and the report is absolutely right to suggest that there are no further blanket rules in place but that decisions are based upon scientific knowledge and are made on a breed by breed basis. This is why we are well on the way to creating a new database which will revolutionise the way that we record dog health data. The data will enable us to bring out our Mate Select programme, which will help breeders to find suitable mating pairs which are most likely to produce healthy offspring. The database will go further than the report's recommendation, as the data will be attributable to specific dogs, rather than being anonymous, and will give us a better picture of the health of pedigrees and crossbreeds. Such knowledge is critical and will enable us to provide information to breeders, vets, geneticists and ultimately the puppy buyer.
"We are keen to harness as much knowledge as possible for the benefit of dogs so we welcome the principle of an advisory council whose members will work with the Kennel Club to advise on decisions about breeding and health. A structure already exists in the form of the Kennel Club's Dog Health Group with its recently extended remit. Additional independent experts include canine and human geneticists, veterinary surgeons and an epidemiologist. Using this framework for establishing the advisory council under an independent chairman would save significant sums of money, which can instead be devoted entirely to the dog health research that the report identified as being in 'urgent' need of more funding."
The Kennel Club and Dogs Trust will now arrange a meeting between all relevant parties in order to move forward with the recommendations from all three reports.
The full report may be downloaded at www.dogbreedinginquiry.com
The National Association of Veterinary Physiotherapists (NAVP) is calling for the Royal College of Veterinary Surgeons (RCVS) to establish an independent register of veterinary physiotherapy practitioners. According to the Association, such a register would eliminate individuals practicing without proper training and qualifications and raise the standard of veterinary physiotherapy by providing a disciplinary role.
NAVP President and leading veterinary anatomist Dr Sue Kempson is heading the NAVP campaign for the establishment of an independent register. In a letter to the President of the RCVS, Dr Kempson said: "Recognition by the veterinary profession of the role of physiotherapy in post-operative rehabilitation and in supporting both companion and performance animals is growing. However, we do believe that referring veterinary surgeons are increasingly faced with a dilemma caused by the wide differential between qualifications offered by the various organisations representing practitioners in areas such as physiotherapy. There is an urgent need for a distinction to be made between these different types of qualification. To this end, there should be a clearly defined independent register of practitioners with appropriately validated qualifications which are clearly understood by the veterinary profession."
In partnership with Harper Adams University College, the NAVP has introduced a fully-validated post-graduate course in veterinary physiotherapy which offers a choice of Post-Graduate Diploma or Masters Degree. Only one other professional body, the Association of Chartered Physiotherapists in Animal Therapy (ACPAT) currently offers a similar qualification at this level.
Dr Kempson said: "The establishment of a register of physiotherapists would greatly assist vets and their clients to make informed decisions on their choice of therapist. It would eliminate those individuals without proper training and qualifications and help raise the standard of veterinary physiotherapy by providing a disciplinary role. At present there are no sanctions on those people practicing without the necessary qualifications or those whose work is sub-standard or who are guilty of professional misconduct.
"We do not believe that such a register should rest with any individual professional body or be affiliated to specific educational courses. To have authority, it requires independence and a register held under the auspices of the Royal College of Veterinary Surgeons would carry the credibility that the veterinary profession requires."
CEVA Animal Health is rolling out what it describes as a hard-hitting TV campaign on four national TV channels to highlight awareness of stress related feline behaviour problems and encourage cat owners to talk to their vet about Feliway.
This second bout of TV advertising will run in March and April on ITV2, ITV3, E4 and More 4 and on Channel 4 in the London region and will be seen by over five million people.
Featuring the animated character 'That Purple Cat' who first appeared in CEVA's TV advertising and marketing push at the end of 2009, the new campaign will see 'That Purple Cat' displaying signs of stress in the home environment to raise awareness of the issue amongst cat owners.
Lucy Brett, product manager at CEVA Animal Health said: "Our first TV advertising campaign back in the autumn went a long way to raise awareness. We found that more cat owners were able to recall the advertising for Feliway than for any other animal health brand.
"However, it is clear that in practice merchandising is crucial if practices are to make the most of this opportunity and I would encourage them to get in touch to request a display pack, which includes a waiting room poster and leaflets, as soon as possible."
A limited number of desktop and floor standing merchandising units are also available. For more information or to order your FREE waiting room merchandising materials call 01494 781510.
Virbac Animal Health has launched a new pet owner information pack to help practices raise awareness of reproductive health issues in dogs and cats.
The pack consists of a leaflet holder with four different leaflets covering unwanted sexual behaviour, castration, prostate disease and misalliance. The holder has a small footprint so will sit nicely in any practice reception area.
Product manager Chris Geddes MRCVS says that the pack will make it easier for vets and VNs to raise the sensitive issue of pet reproductive health with owners. "For example, prostate disease in men is well documented and public knowledge is high, but we believe that few people know that it can affect pets too.
"It is estimated that 80% of male dogs over the age of five suffer from prostate problems, but experts agree that it is underdiagnosed at present. This is possibly due to a combination of a lack of awareness and client unease on discussing reproductive subjects at their vet practice."
To obtain your free pack or for further information, please contact your local territory manager or call Virbac on 01359 243243.